Jingxing Zhou

Statistics

Publications

Citations

314

H-Index

Active since

2022

Affiliations

Center for Excellence in Brain Science and Intelligence Technology(Current)

Chinese Academy of Sciences

NewGen Therapeutics (United States)

Regend Therapeutics (China)

First Affiliated Hospital of Fujian Medical University

Jingxing Zhou is an author at Center for Excellence in Brain Science and Intelligence Technology specializing in biotechnology, life sciences, and base editing.

Publications per year

2022–2024

Publications

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing

Xiangfeng Kong, Hainan Zhang, Guoling Li et al. · Nature Communications · 2023 · 95 citations · Full text

Life Sciences, Biotechnology, Genetics +14

Development of miniature base editors using engineered IscB nickase

Dingyi Han, Qingquan Xiao, Yifan Wang et al. · Nature Methods · 2023 · 88 citations

Life Sciences, Biotechnology, Computer Science +6

Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase

Huawei Tong, Nana Liu, Yinghui Wei et al. · National Science Review · 2023 · 74 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +11

Engineered IscB–ωRNA system with expanded target range for base editing

Qingquan Xiao, Guoling Li, Dingyi Han et al. · Nature Chemical Biology · 2024 · 35 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +14

An engineered xCas12i with high activity, high specificity and broad PAM range

Hainan Zhang, Xiangfeng Kong, Mingxing Xue et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 22 citations · Full text

Engineering, Bioengineering, Biotechnology +2

1–5 of 5